Boothbay Fund Management’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-50,000
| Closed | -$965K | – | 1508 |
|
|
2025
Q1 | $965K | Buy |
+50,000
| New | +$965K | 0.03% | 515 |
|
|
2024
Q2 | – | Sell |
-35,000
| Closed | -$145K | – | 1636 |
|
|
2024
Q1 | $145K | Buy |
35,000
+5,000
| +17% | +$20.7K | ﹤0.01% | 1207 |
|
|
2023
Q4 | $78.3K | Hold |
30,000
| – | – | ﹤0.01% | 1293 |
|
|
2023
Q3 | $56.1K | Hold |
30,000
| – | – | ﹤0.01% | 1423 |
|
|
2023
Q2 | $75.3K | Sell |
30,000
-126,995
| -81% | -$319K | ﹤0.01% | 1421 |
|
|
2023
Q1 | $275K | Sell |
156,995
-64,210
| -29% | -$112K | 0.01% | 1338 |
|
|
2022
Q4 | $940K | Buy |
+221,205
| New | +$940K | 0.02% | 760 |
|
|
2022
Q3 | – | Sell |
-81,559
| Closed | -$82K | – | 2266 |
|
|
2022
Q2 | $82K | Sell |
81,559
-73,391
| -47% | -$73.8K | ﹤0.01% | 1750 |
|
|
2022
Q1 | $380K | Buy |
+154,950
| New | +$380K | 0.01% | 1149 |
|